Can eye tracking reveal hidden effects of thyroid eye disease?

NCT ID NCT07381413

Recruiting now Knowledge-focused Sponsor: Shanghai Changzheng Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses a non-invasive eye tracker to measure how well people with Thyroid-Associated Ophthalmopathy (TAO) can move their eyes and pay attention to faces. Researchers will compare 100 participants, including patients and healthy volunteers, to see if the disease causes measurable differences in eye stability and scanning patterns. The goal is to better understand the physical and social impact of TAO, which could help guide future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide objective measures to better understand and monitor how thyroid eye disease affects eye movement and social interaction.
What could go wrong: This is a small, early observational study, not a treatment trial. The findings may not lead to direct clinical changes or apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EYE TRACKING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endocrine exophthalmos Graves Ophthalmopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EYE TRACKING THYROID ASSOCIATED OPHTHALMOPATHIES

Contacts and locations

Locations

Changzheng Hospital
RECRUITING

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.